Cellulite Treatment Market Research Report—Global Forecast till 2032

Cellulite Treatment Market Research Report Information By Treatment Procedure (Non-Invasive, Minimally-Invasive, Topical Treatment), By Cellulite Type (Hard Cellulite, Soft Cellulite, Edematous Cellulite), By End Use (Hospitals, Ambulatory Surgical Centers, Specialized Dermatology Clinics), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

ID: MRFR/HC/7665-CR | 95 Pages | Author: Rahul Gotadki | January 2022         

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING NUMBER OF OBESE CASES ACROSS THE GLOBE

4.2.2 RISING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES

4.2.3 GROWING MEDICAL TOURISM INDUSTRY

4.3 RESTRAINTS

4.3.1 CONCERNS PERTAINING TO BRUISING AND SWELLING

4.3.2 SHORTAGE OF TRAINED AND EXPERIENCED DERMATOLOGIST/ PLASTIC SURGEON

4.4 OPPORTUNITY

4.4.1 GROWING ADOPTION OF COSMETIC PROCEDURES IN EMERGING ECONOMIES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL CELLULITE TREATMENT MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PATIENTS SUFFERING FROM CELLULITE

5.3.3 IMPACT ON DEMAND AND SUPPLY

5.3.4 IMPACT ON REGIONS

6 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE

6.1 OVERVIEW

6.2 NON-INVASIVE

6.3 TOPICAL

6.4 MINIMALLY INVASIVE

6.5 OTHERS

7 GLOBAL CELLULITE TREATMENT MARKET, BY CELLULITE TYPE

7.1 OVERVIEW

7.2 SOFT CELLULITE

7.3 HARD CELLULITE

7.4 EDEMATOUS CELLULITE

8 GLOBAL CELLULITE TREATMENT MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS

8.3 SPECIALISED DERMATOLOGY CLINICS

8.4 AMBULATORY SURGICAL CENTERS

8.5 OTHERS

9 GLOBAL CELLULITE TREATMENT MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA PACIFIC

9.4.1 CHINA

9.4.2 JAPAN

9.4.3 INDIA

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CELLULITE TREATMENT MARKET

10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL CELLULITE TREATMENT MARKET

10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.5.1 PRODUCT LAUNCH/PRODUCT APPROVAL

11 COMPANY PROFILES

11.1 HOLOGIC, INC.

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS/SERVICES OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 NUBWAY CO.LTD.

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS/SERVICES OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 MERZ PHARMA GMBH & CO. KGAA

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS/SERVICES OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 ZIMMER AESTHETICS

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS/SERVICES OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.4.6 KEY STRATEGIES

11.5 CYMEDICS

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS/SERVICES OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.5.6 KEY STRATEGIES

11.6 CYNOSURE, LLC

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS/SERVICES OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 INCELER MEDIKAL CO. LTD.

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS/SERVICES OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 CANDELA MEDICAL

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS/SERVICES OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 KEY STRATEGIES

11.9 CUTERA, INC.

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS/SERVICES OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 KEY STRATEGIES

11.10 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS/SERVICES OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL: CELLULITE TREATMENT MARKET, FOR NON-INVASIVE, BY REGION, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: CELLULITE TREATMENT MARKET, FOR TOPICAL, BY REGION, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: CELLULITE TREATMENT MARKET, FOR MINIMALLY INVASIVE, BY REGION, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: CELLULITE TREATMENT MARKET, FOR SOFT CELLULITE, BY REGION, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: CELLULITE TREATMENT MARKET, FOR HARD CELLULITE, BY REGION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: CELLULITE TREATMENT MARKET, FOR EDEMATOUS CELLULITE, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: CELLULITE TREATMENT MARKET, FOR HOSPITALS, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: CELLULITE TREATMENT MARKET, FOR SPECIALISED DERMATOLOGY CLINICS, BY REGION, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: CELLULITE TREATMENT MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: CELLULITE TREATMENT MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 19 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 20 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 21 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 22 US: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 23 US: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 24 US: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 25 CANADA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 26 CANADA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 27 CANADA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 28 EUROPE: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 29 EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 30 EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 31 EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 32 GERMANY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 33 GERMANY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 34 GERMANY: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 35 UK: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 36 UK: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 37 UK: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 38 FRANCE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 39 FRANCE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 40 FRANCE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 41 ITALY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 42 ITALY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 43 ITALY: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 44 SPAIN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 45 SPAIN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 46 SPAIN: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 47 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 48 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 49 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 50 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 51 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 52 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 53 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 54 CHINA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 55 CHINA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 56 CHINA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 57 JAPAN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 58 JAPAN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 59 JAPAN: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 60 INDIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 61 INDIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 62 INDIA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 63 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 64 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 65 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 66 AUSTRALIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 67 AUSTRALIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 68 AUSTRALIA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 69 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 70 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 71 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 72 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 73 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 74 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 75 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 76 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 77 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 78 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 79 AFRICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 80 AFRICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 81 AFRICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 82 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 83 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 84 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 85 MAJOR PLAYERS IN THE GLOBAL CELLULITE TREATMENT MARKET

TABLE 86 MOST ACTIVE PLAYER IN THE GLOBAL CELLULITE TREATMENT MARKET

TABLE 87 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 88 HOLOGIC, INC: PRODUCTS/SERVICES OFFERED

TABLE 89 NUBWAY CO.LTD.: PRODUCTS/SERVICES OFFERED

TABLE 90 MERZ PHARMA GMBH & CO. KGAA: PRODUCTS/SERVICES OFFERED

TABLE 91 ZIMMER AESTHETICS: PRODUCTS/SERVICES OFFERED

TABLE 92 CYMEDICS: PRODUCTS/SERVICES OFFERED

TABLE 93 CYNOSURE, LLC: PRODUCTS/SERVICES OFFERED

TABLE 94 INCELER MEDIKAL CO. LTD.: PRODUCTS/SERVICES OFFERED

TABLE 95 CANDELA MEDICAL: PRODUCTS/SERVICES OFFERED

TABLE 96 CUTERA, INC.: PRODUCTS/SERVICES OFFERED

TABLE 97 CUTERA, INC.: KEY DEVELOPMENTS

TABLE 98 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.: PRODUCTS/SERVICES OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 MARKET STRUCTURE: GLOBAL CELLULITE TREATMENT MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL CELLULITE TREATMENT MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL CELLULITE TREATMENT MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CELLULITE TREATMENT MARKET

FIGURE 9 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL: CELLULITE TREATMENT MARKET, CELLULITE TYPE, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: CELLULITE TREATMENT MARKET, END USER, 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL: CELLULITE TREATMENT MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 13 GLOBAL: CELLULITE TREATMENT MARKET SHARE (%), BY REGION, 2020

FIGURE 14 NORTH AMERICA: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020

FIGURE 15 EUROPE: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020

FIGURE 16 ASIA PACIFIC: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020

FIGURE 17 REST OF THE WORLD: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020

FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 19 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CELLULITE TREATMENT MARKET

FIGURE 20 HOLOGIC, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 HOLOGIC, INC: SWOT ANALYSIS

FIGURE 22 NUBWAY CO.LTD.: SWOT ANALYSIS

FIGURE 23 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS

FIGURE 24 ZIMMER AESTHETICS: SWOT ANALYSIS

FIGURE 25 CYMEDICS: SWOT ANALYSIS

Market Segmentation


Cellulite Treatment Treatment Procedure Outlook (USD Billion, 2018-2030)




  • Non-Invasive




  • Minimally-Invasive




  • Topical Treatment




Cellulite Treatment Cellulite Type Outlook (USD Billion, 2018-2030)




  • Hard Cellulite




  • Soft Cellulite




  • Edematous Cellulite




Cellulite Treatment End Use Outlook (USD Billion, 2018-2030)




  • Hospitals




  • Ambulatory Surgical Centers




  • Specialized Dermatology Clinics




Cellulite Treatment Regional Outlook (USD Billion, 2018-2030)




  • North America Outlook (USD Billion, 2018-2030)




    • North America Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • North America Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • North America Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • US Outlook (USD Billion, 2018-2030)




    • US Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • US Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • US Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Canada Outlook (USD Billion, 2018-2030)




    • Canada Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Canada Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Canada Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics








  • Europe Outlook (USD Billion, 2018-2030)




    • Europe Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Europe Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Europe Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Germany Outlook (USD Billion, 2018-2030)




    • Germany Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Germany Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Germany Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • France Outlook (USD Billion, 2018-2030)




    • France Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • France Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • France Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • UK Outlook (USD Billion, 2018-2030)




    • UK Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • UK Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • UK Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Italy Outlook (USD Billion, 2018-2030)




    • Italy Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Italy Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Italy Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Spain Outlook (USD Billion, 2018-2030)




    • Spain Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Spain Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Spain Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Rest Of Europe Outlook (USD Billion, 2018-2030)




    • Rest Of Europe Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Rest Of Europe Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Rest Of Europe Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics








  • Asia-Pacific Outlook (USD Billion, 2018-2030)




    • Asia-Pacific Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Asia-Pacific Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Asia-Pacific Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • China Outlook (USD Billion, 2018-2030)




    • China Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • China Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • China Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Japan Outlook (USD Billion, 2018-2030)




    • Japan Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Japan Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Japan Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • India Outlook (USD Billion, 2018-2030)




    • India Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • India Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • India Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Australia Outlook (USD Billion, 2018-2030)




    • Australia Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Australia Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Australia Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)




    • Rest of Asia-Pacific Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Rest of Asia-Pacific Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Rest of Asia-Pacific Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics








  • Rest of the World Outlook (USD Billion, 2018-2030)




    • Rest of the World Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Rest of the World Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Rest of the World Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Middle East Outlook (USD Billion, 2018-2030)




    • Middle East Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Middle East Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Middle East Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Africa Outlook (USD Billion, 2018-2030)




    • Africa Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Africa Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Africa Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics






    • Latin America Outlook (USD Billion, 2018-2030)




    • Latin America Cellulite Treatment by Treatment Procedure




      • Non-Invasive




      • Minimally-Invasive




      • Topical Treatment






    • Latin America Cellulite Treatment by Cellulite Type




      • Hard Cellulite




      • Soft Cellulite




      • Edematous Cellulite






    • Latin America Cellulite Treatment by End Use




      • Hospitals




      • Ambulatory Surgical Centers




      • Specialized Dermatology Clinics







Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid

Research Methodology on Cellulite Treatment Market


1. Introduction


Cellulite Treatment Market comprises various solutions which are used for the treatment of cellulite on different parts of the body such as the thighs, butt, and abdomen. The current demand for non-invasive techniques for the treatment and changing lifestyle patterns are augmenting the market growth.


This research report provides an in-depth analysis of the global Cellulite Treatment Market in terms of market size and forecast for 2023 to 2030. The report provides insights into the latest developments and trends in the market. It also evaluates the competitive landscape of the market through secondary sources.


2. Objectives of the Study


The objective of this research study is to analyze the market trends in terms of size, share, pricing structure, growth drivers, emerging trends, and other relevant factors. The study also includes an analysis of the competitive landscape of the market.


3. Research Scope


The scope of this research study is to analyze the global Cellulite Treatment Market, both in terms of value and volume. The market analysis has been conducted across five key regions – North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.


4. Research Methodology


This research study has used both primary and secondary research sources to collect data and information on the global Cellulite Treatment Market. The primary research sources included industry experts and market analysts.


The secondary research sources included annual reports, company websites, press releases, and financial reports. The research used a bottom-up approach to estimate the market size in terms of value and volume. It also used an appropriate combination of qualitative and quantitative research methods to analyze the market dynamics and trends.


5. Market Estimation and Forecast


The market estimates and forecasts were based on the analysis of the global Cellulite Treatment Market. The data was gathered from both primary and secondary sources. The primary sources included external and internal sources, such as press releases, industry surveys, interviews with industry experts, and press interviews.


The secondary sources included databases such as Factiva, Bloomberg, and Marketing Intelligence Tools. The data was further validated by conducting multiple rounds of validation with industry experts and experts from the industry.


The market was segmented based on geography, technology, product type, and application. The market size and forecast were estimated based on the analysis of the data collected from primary and secondary sources.


The market estimates and forecasts were calculated using statistical tools such as arithmetic mean, median, mode, standard deviation, and Z-Score Analysis. The market estimates and forecasts were validated using past data analysis and market trends.


6. Data Collection and Analysis


The data used for the research was collected from both primary and secondary sources. The primary sources consisted of industry experts, industry publications, surveys, and interviews. The secondary sources included Factiva, Bloomberg, and Marketing Intelligence Tools.


The data were analyzed using statistical tools such as mean, median, mode, and standard deviation. The data was further validated using the top-down approach and bottom-up approach. The data were also analyzed using the Z-Score Analysis to validate the results.


7. Results and Findings


The results of the research study are summarized as follows:




  • The Cellulite Treatment Market is estimated to expand at a significant CAGR from 2023 to 2030.




  • North American region holds a significant share of the global Cellulite Treatment Market.




  • The market is segmented based on technology, product type, and application.




  • The growth of the market is driven by the rising prevalence of cellulite, increasing awareness among consumers, and preference for non-invasive treatment options.




  • The key players in the market include Cynosure, Inc., Solta Medical, Inc., Lumenis, Merz Pharma GmbH & Co. KGaA, Integra LifeSciences Corporation, and Teoxane Laboratories.



Speak to Analyst